PubMed Health⌕ Search

Biomedical subjects

G L Navarre

Publications and source records attributed to G L Navarre.

4 recordsLinked to original sources

Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis.

OBJECTIVE: To examine the clinical usefulness of the Bethesda classification system of low-grade cervicovaginal cytology as it relates to predicting underlying histology and aiding in triage to colposcopy. METHODS: We evaluated 1454 women with abnormal cytologic screening results: 782 with atypical squamous cells of uncertain significance (atypia), 355 with low-grade squamous intraepithelial lesions (SIL) determined by the presence of human papillomavirus (HPV) alone, and 317 with low-grade SIL determined by the presence of cytologic evidence of mild dysplasia (cervical intraepithelial neoplasia [CIN] I) devoid of HPV cytopathologic features. All women underwent colposcopy, directed-punch biopsy or loop electrosurgical excision, and/or endocervical curettage (ECC), as indicated. RESULTS: Women from the low-grade SIL-CIN I referral cytology group were significantly more likely to harbor all grades of biopsy-proven dysplasia than were those from the atypical squamous cells of uncertain significance and low-grade SIL-HPV groups, which showed no statistical differences. CONCLUSIONS: Contrary to the Bethesda system, which combines CIN I and HPV changes because of cytomorphologic similarities, this study suggests that patients with HPV cytologic smears are similar to patients with atypical smears and are less likely to harbor any biopsy-proven CIN lesions than are patients with CIN I cervicovaginal smears. If excluded from colposcopic triage, approximately 5% of patients with atypical cytologic smears from a well-screened population similar to ours will harbor high-grade lesions that may progress during any waiting period. Triage of low-grade cervicovaginal smears based on histopathologic correlation is encouraged.

Adult↗

Screening with colposcopy in a prepaid health center.

The early detection of cervical cancer by widespread application of the Papanicolaou (Pap) smear has produced a decrease in U.S. mortality rates from this disease. Colposcopy is a useful adjunct in evaluating patients with an abnormal Pap smear. The author's five years of experience using the colposcope for primary screening detected 146 patients with cervical lesions, 30 with moderate dysplasia or worse and 116 with minimal or mild dysplasia. Estimated incidence by type of appointment showed the highest incidence of significant pathology (approximately one lesion per 115 patients) in patients who were seen without appointments. In 19 patients their disease would have been missed by routine Pap smear but was detected by the colposcope. Gynecologists who are trained in the use of this instrument should use it in conjunction with the Pap smear to help detect pathology in new patients.

Carcinoma in Situ↗

Trends in colposcopy.

Concurrent with the decreasing incidence of invasive squamous cell cancer of the cervix, there has been an increase in the incidence of cervical carcinoma in situ (CIS). The incidence of CIS has reached a plateau, and the author feels that CIS will now decline as earlier stages of cervical intraepithelial neoplasia (CIN) are being detected and eradicated. Much of the treatment of this earlier CIN can be confined to an office setting with the aid of a colposcope.

California↗